US$ 24.22
asa glp-1 agonist guidelines How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Holding GLP-1 Agonists Prior to
Description
The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects

Touny AA, Kenny E, Mnsson M, Webb DL, Hellstrm PM

Collectively, these insights position GLP-1 and its analogs as versatile and promising agents in the broader context of metabolic disease management

Awareness prevents these issues
